Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  Check Out View Cart

Country Report

Analgesics in

Analgesics in Japan

21 pages, Oct 2017

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

Robust growth expected for analgesics

Analgesics in Japan recorded healthy current value growth in 2017. Systemic analgesics containing ibuprofen as a main active ingredient performed well, as did combination products containing ibuprofen or loxoprofen.

Domestic players establish specialised OTC companies

In recent years leading domestic pharmaceutical manufacturers in Japan have established separate companies that focus on OTC products, including analgesics. Shionogi & Co Ltd established Shionogi Healthcare & Co Ltd in April 2016, for example, while Takeda Pharmaceutical Co Ltd established Takeda Consumer Healthcare Co Ltd in April 2017.

Loxoprofen sodium hydrate products approved for switching

The first OTC topical analgesics/anaesthetic products in Japan containing loxoprofen sodium hydrate were approved for switching in 2015, and went on sale in August 2016. Like all new switches, these products will be classified as “guidance-required” for the first three years, with their dosage of loxoprofen sodium hydrate fixed at 25% of that found in prescription-only products.

COMPETITIVE LANDSCAPE

SSP the leading player in systemic analgesics

SSP continued to lead systemic analgesics in 2017 thanks to its popular Eve brand, with its performance being bolstered by the government’s push to promote self-medication. Lion Corp ranked second with its Bufferin brand, followed by Daiichi Sankyo with Loxonin S and Taisho Pharmaceutical with Naron.

Hisamitsu the leading player in topical analgesics/anaesthetic

Hisamitsu maintained its long-standing lead in the topical analgesics/anaesthetic category in 2017 thanks to the combined strength of its Salonpas, Faitas, Salonsip and Air Salonpas brands. It continued to release new products and run promotional campaigns throughout the year.

Daiichi Sankyo looking to double the sales of its Loxonin S brand

Daiichi Sankyo continued to actively advertise adult combination products and topical analgesics/anaesthetic products sold under its Loxonin S brand in 2017. The company aims to double sales of this brand between 2015 and the end of the 2020 fiscal year.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Analgesics Market Sample Report Analgesics Market Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Japan with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Japan, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Japan market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Analgesics in Japan?
What are the major brands in Japan?
Are combination products with acetaminophen still popular?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Analgesics in Japan - Category analysis

HEADLINES

PROSPECTS

Robust growth expected for analgesics

Domestic players establish specialised OTC companies

Loxoprofen sodium hydrate products approved for switching

COMPETITIVE LANDSCAPE

SSP the leading player in systemic analgesics

Hisamitsu the leading player in topical analgesics/anaesthetic

Daiichi Sankyo looking to double the sales of its Loxonin S brand

CATEGORY DATA

Table 1 Sales of Analgesics by Category: Value 2012-2017
Table 2 Sales of Analgesics by Category: % Value Growth 2012-2017
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2012-2017
Table 4 NBO Company Shares of Analgesics: % Value 2013-2017
Table 5 LBN Brand Shares of Analgesics: % Value 2014-2017
Table 6 Forecast Sales of Analgesics by Category: Value 2017-2022
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2017-2022

Consumer Health in Japan - Industry Overview

EXECUTIVE SUMMARY

Consumer health benefits from new tax system designed to promote self-medication

New consumer health products target specific demographic groups

Competitive environment in consumer health remains fragmented

Market value share of drugstores/parapharmacies channel increases

Consumer health set to benefit from self-medication and diversification

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 9 Life Expectancy at Birth 2012-2017

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2012-2017
Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
Table 15 Distribution of Consumer Health by Format: % Value 2012-2017
Table 16 Distribution of Consumer Health by Format and Category: % Value 2017
Table 17 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

Summary 1 OTC: Switches 2015-2017

DEFINITIONS

SOURCES

Summary 2 Research Sources

Why buy this report?

Want to find out more about this report?

Request more information

Megatrends

Country Report

Analgesics in Japan

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

Robust growth expected for analgesics

Domestic players establish specialised OTC companies

Loxoprofen sodium hydrate products approved for switching

COMPETITIVE LANDSCAPE

SSP the leading player in systemic analgesics

Hisamitsu the leading player in topical analgesics/anaesthetic

Daiichi Sankyo looking to double the sales of its Loxonin S brand

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Analgesics in Japan - Category analysis

HEADLINES

PROSPECTS

Robust growth expected for analgesics

Domestic players establish specialised OTC companies

Loxoprofen sodium hydrate products approved for switching

COMPETITIVE LANDSCAPE

SSP the leading player in systemic analgesics

Hisamitsu the leading player in topical analgesics/anaesthetic

Daiichi Sankyo looking to double the sales of its Loxonin S brand

CATEGORY DATA

Consumer Health in Japan - Industry Overview

EXECUTIVE SUMMARY

Consumer health benefits from new tax system designed to promote self-medication

New consumer health products target specific demographic groups

Competitive environment in consumer health remains fragmented

Market value share of drugstores/parapharmacies channel increases

Consumer health set to benefit from self-medication and diversification

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

DEFINITIONS

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports